Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

703.30INR
6:15am EDT
Change (% chg)

Rs-0.55 (-0.08%)
Prev Close
Rs703.85
Open
Rs702.90
Day's High
Rs709.80
Day's Low
Rs701.00
Volume
157,693
Avg. Vol
445,281
52-wk High
Rs854.50
52-wk Low
Rs572.40

Latest Key Developments (Source: Significant Developments)

Almirall says regulatory filing for Tildrakizumab in Europe is validated
2:57am EDT 

Almirall SA :The company and Sun Pharma announce validation of regulatory filing for Tildrakizumab, an antibody designed for treatment of moderate-to-severe plaque psoriasis, by the European Medicines Agency (EMA).  Full Article

Sun Pharma says filing of tildrakizumab with European Medicines Agency by Almirall
12:53am EDT 

Sun Pharmaceutical Industries Ltd : Says validation of regulatory filing of tildrakizumab with the european medicines agency (EMA) by Almirall. . Tildrakizumab is an investigational IL-23P19 inhibitor being evaluated for the treatment of moderate-to-severe plaque psoriasis. .Filing includes efficacy, safety data from pivotal phase III clinical trials that included over 1,800 patients.  Full Article

Sun Pharma Industries says Canadian unit to acquire Thallion Pharma
Friday, 17 Mar 2017 05:41am EDT 

Sun Pharmaceutical Industries Ltd : Says deal for c$2.3 million . Taro Pharmaceuticals Inc. (Canada) entered into deal to acquire all issued and outstanding shares of Thallion Pharma . Consideration would be in cash . Post deal, no turnover expected of existing products as all revenue-producing assets have been transferred from Thallion to Bellus Health . Post acquisition of Thallion, Taro Pharma would have only rights for development of orphan drug candidate, Shigamab .No material effect of acquisition by Taro Pharmaceuticals (Canada) on consol revenue, expenses or profits of co.  Full Article

Sun Pharmaceutical Industries says USFDA will lift import alert on Mohali manufacturing facility
Tuesday, 14 Mar 2017 04:22am EDT 

Sun Pharmaceutical Industries Ltd : Says USFDA will lift the import alert imposed on the Mohali (Punjab) manufacturing facility .Says USFDA will remove Mohali facility from the official action initiated status.  Full Article

Sun Pharmaceutical Industries says European Medicines Agency approves Tobramycin
Thursday, 16 Feb 2017 04:29am EST 

Sun Pharmaceutical Industries Ltd : Sun Pharmaceutical Industries clarifies on news item "UK regulator approves Sun Pharma generic drug of Tobramycin" .Approval for product, is not from UK regulator but from European Medicines Agency.  Full Article

Sun Pharma to buy Novartis' cancer drug Odomzo
Wednesday, 21 Dec 2016 10:01pm EST 

Sun Pharmaceutical Industries Ltd : Says Sun Pharma to acquire branded oncology product Odomzo for global markets . Says acquisition of Odomzo from Novartis . Says greement has been signed for an upfront payment of US$ 175 million and additional milestone payments. .says Odomzo is used for treatment of adult patients with labcc that has recurred following surgery or radiation therapy.  Full Article

Sun Pharmaceutical Industries announces voluntary withdrawal of 28 ANDAs
Monday, 19 Dec 2016 09:48pm EST 

Sun Pharmaceutical Industries Ltd : Says older drug products belong to erstwhile ranbaxy laboratories ltd. And are not being marketed in us since 2008 .Says voluntary withdrawal of 28 ANDAs.  Full Article

Sun Pharmaceutical Industries says USFDA cites nine inspectional observations at Halol facility
Thursday, 8 Dec 2016 04:15am EST 

Sun Pharmaceutical Industries Ltd : USFDA inspected the company's Halol facility in Gujarat, India from November 17, 2016 through December 1, 2016 . At the conclusion of the inspection, the USFDA issued a Form-483, citing nine inspectional observations . Says intends to implement promptly any corrective actions that may be necessary as a result of the observations .None of the observations were characterized by the USFDA as repeat observations.  Full Article

Sun Pharma enters into deal to buy 85.1 pct of Russia's JSC Biosintez
Tuesday, 22 Nov 2016 09:51pm EST 

Sun Pharmaceutical Industries Ltd : Says company has entered into an agreement to acquire 85.1% of JSC Biosintez, a Russian pharmaceutical company . Days deal expected to be completed by end of 2016 . Equity consideration for shares acquired is RUB 1,526 million or approx. USD 24 million .Sun Pharma would also assume a debt of approximately USD$ 36 million as part of this transaction.  Full Article

Sun Pharmaceutical Industries signs tri-party agreement to launch malaria free India
Tuesday, 15 Nov 2016 03:41am EST 

Sun Pharmaceutical Industries Ltd : Sun Pharmaceutical Industries Ltd says Sun Pharma signing tri-party agreement to launch malaria free India . Sun Pharmaceutical Industries -agreement allows other government or private stakeholders to join Mandla project,similar project in partnership with FDEC-India . Sun Pharmaceutical Industries - ICMR, government of MP, FDEC-India sign tri-party agreement to launch malaria free India demonstration project in Mandla district .Sun Pharmaceutical Industries - project to be launched across 1,233 villages in Mandla by january 2017.  Full Article

More From Around the Web

BRIEF-Sun Pharma says filing of tildrakizumab with European Medicines Agency by Almirall

* Says validation of regulatory filing of tildrakizumab with the european medicines agency (EMA) by Almirall.